- Home
- RNA vs MAC Comparison
RNA vs MAC Comparison
Compare RNA & MAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- MAC
- Stock Information
- Founded
- RNA 2012
- MAC 1964
- Country
- RNA United States
- MAC United States
- Employees
- RNA N/A
- MAC N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- MAC Real Estate Investment Trusts
- Sector
- RNA Health Care
- MAC Real Estate
- Exchange
- RNA Nasdaq
- MAC Nasdaq
- Market Cap
- RNA 4.4B
- MAC 4.6B
- IPO Year
- RNA 2020
- MAC 1994
- Fundamental
- Price
- RNA $32.74
- MAC $21.39
- Analyst Decision
- RNA Strong Buy
- MAC Hold
- Analyst Count
- RNA 10
- MAC 11
- Target Price
- RNA $63.60
- MAC $18.42
- AVG Volume (30 Days)
- RNA 1.1M
- MAC 2.8M
- Earning Date
- RNA 11-07-2024
- MAC 02-05-2025
- Dividend Yield
- RNA N/A
- MAC 3.14%
- EPS Growth
- RNA N/A
- MAC N/A
- EPS
- RNA N/A
- MAC 0.36
- Revenue
- RNA $10,117,000.00
- MAC $788,288,000.00
- Revenue This Year
- RNA N/A
- MAC N/A
- Revenue Next Year
- RNA N/A
- MAC $3.53
- P/E Ratio
- RNA N/A
- MAC $59.62
- Revenue Growth
- RNA N/A
- MAC N/A
- 52 Week Low
- RNA $8.37
- MAC $12.99
- 52 Week High
- RNA $56.00
- MAC $22.27
- Technical
- Relative Strength Index (RSI)
- RNA 30.43
- MAC 60.18
- Support Level
- RNA $32.04
- MAC $20.83
- Resistance Level
- RNA $34.35
- MAC $21.80
- Average True Range (ATR)
- RNA 2.07
- MAC 0.51
- MACD
- RNA -0.55
- MAC -0.08
- Stochastic Oscillator
- RNA 6.24
- MAC 50.58
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About MAC Macerich Company (The)
The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.